I would build an **age-conditioned PPG physiological risk score**, then consider expressing it in years. VitalDB can establish health information beyond age; establishing biological aging requires independent outcomes and longitudinal validation.

I read the requested code and [report](reports/PPG foundation models and aging clocks 2026.md). Run 2/3 artifacts are absent from this checkout, so their results come from the report. No files changed.

The diagnosis is that **predicting age and measuring physiological deterioration are different objectives**.

The encoder supplies a 256-dimensional embedding, but `AgeHead` compresses it to one number using smooth-L1 age loss. Health information can occupy directions that contribute little to age prediction. The trait head receives direct supervision to find those directions. Residualizing the age prediction cannot recover information discarded by that projection.

Several features of this setup reinforce the distinction:

- **Shrinkage and regression dilution:** age predictions regress toward the population center. Validation-based correction removes the fitted linear age trend; it does not turn prediction error into physiological variation. Any small health component remaining in a noisy gap suffers attenuation when used to predict outcomes.
- **Pretraining:** next-second prediction rewards waveform predictability; same-person contrast rewards stable identity, including anatomy and recording characteristics. Neither explicitly rewards deterioration or future risk.
- **Lost information:** robust scaling removes absolute amplitude, while mean pooling suppresses response timing. Training resets recurrent state for every 30-second window.
- **Targets and cohort:** treated hypertension and diabetes need not produce abnormal intraoperative pulses. Diagnoses imperfectly describe current physiology; anesthesia and vasoactive treatment alter it. ASA summarizes broader illness, making it a more compatible target, although also a subjective one.
- **Healthy-only training changes the reference population, not the objective.** Its failure weakens the hypothesis that illness generally moves patients along the learned age axis.

Finally, gap-only AUC near 0.5 is not a complete conditional-independence test: age interactions or nonlinear gap effects could remain. Test `outcome ~ spline(age) + gap`, too.

For all candidates, preserve the existing **4,071/912/897 person split**. Select penalties and architectures using inner cross-validation within training; use validation for calibration; evaluate one locked specification on test. All preprocessing, residualization and dimensionality reduction must be fitted without test data.

The mandatory comparator should be **age splines + sex**. The current [`_beyond_age`](src/kron_ppg/traits.py:248) uses linear age alone. Add BMI, procedure, HR, quality and conventional morphology as sensitivity comparators. Report paired person-bootstrap ΔAUC, PR-AUC, log loss, calibration, and discrimination within age bands.

Ranked by expected value:

1. **Outcome-anchored morbidity score**

   Start with the frozen run-3 encoder’s final, valid-token mean embedding, before its contrastive projection. Fit a regularized linear head first, then a small MLP:

   \[
   \operatorname{logit}P(\mathrm{ASA}\ge3)=f(A,\mathrm{sex})+h(z).
   \]

   Minimize binary cross-entropy. Add separate auxiliary heads with masked, standardized Huber losses for Hb, albumin and log-creatinine. Avoid treating `healthy` as an independent endpoint: it reuses ASA, hypertension and diabetes.

   This borrows outcome anchoring from [PhenoAge—Levine et al., 2018](https://www.aging-us.com/article/101414/text) and [GrimAge—Lu et al., 2019](https://www.aging-us.com/article/101684/text). Available labs cannot reproduce published PhenoAge, and mortality training is unjustified here.

   **Success:** calibrated incremental ASA prediction, plus cross-target evidence: train a lab-only sibling, excluding ASA from every loss, and test its association with ASA.

   **Years:** where the age-only risk curve is monotonic and sufficiently steep, define \(B=f^{-1}[f(A,\mathrm{sex})+h(z),\mathrm{sex}]\). Call this **ASA-risk-equivalent age**. A years conversion adds no biological evidence and becomes unstable where the curve is flat.

   **Main deception:** learning anesthesia management or clinician-assigned severity rather than durable physiology.

2. **Residualized embeddings, followed by a health probe**

   Fit a ridge spline regression for each embedding coordinate on age and sex; construct:

   \[
   z_\perp=z-\widehat E[z\mid A,\mathrm{sex}].
   \]

   Cross-fit these nuisance models within training. Compare identically regularized ASA heads using raw \(z\) versus \(z_\perp\), retaining age and sex explicitly in the outcome model.

   Only afterward try a 16-dimensional adapter with an age adversary: the adapter minimizes \(L_{\text{health}}-\lambda L_{\text{age}}\), while the adversary minimizes age-bin cross-entropy. Gradient reversal supplies this optimization mechanism; its original application was domain adaptation ([Ganin et al., 2016](https://jmlr.org/papers/v17/15-239.html)).

   **Success:** preserved health prediction within age bands, alongside weak held-out age prediction by fresh nonlinear probes.

   **Main deception:** zero covariance is weaker than independence. Conversely, aggressive age removal can erase real health information because health and age are associated. Perfect age independence should not be the objective.

3. **Dynamic reserve during a documented perturbation**

   This offers the strongest physiological interpretation, with greater preparation cost. The raw case table contains anesthesia timestamps; the track catalog includes propofol and vasopressor infusion rates. Current readers/extras do not expose these sufficiently.

   Extract contiguous periods around verified induction or infusion changes: approximately two minutes before and ten minutes after, requiring adequate baseline coverage. The current evenly thinned windows cannot simply be concatenated.

   Carry `LayerStates`; summarize rolling hidden means, terminal states, changes, variability and recovery slopes. Start frozen. If needed, tune blocks 5–6 using Huber arterial-pressure trajectory loss plus next-patch regularization. Use arterial-line labels for rapid responses.

   Fit health probes on response summaries, conditioning on actual dose, baseline BP/HR, anesthesia and procedure.

   **Success:** incremental ASA or procedure-adjusted postoperative ICU prediction beyond static embeddings; benefit disappears when temporal ordering is shuffled.

   **Main deception:** treatment selection and rescue decisions create the apparent “reserve.” Recorded totals cannot identify bolus timing. This measures perioperative resilience until independently validated.

4. **Supervised age/health/nuisance factor model**

   From frozen embeddings, learn scalar age and health factors plus an eight-dimensional nuisance factor. Decode embeddings with an MSE reconstruction loss; supervise age with Huber loss and health with masked clinical losses. Add an age–health covariance penalty. A variational version adds KL regularization.

   Add matched pairs: same sex, similar procedure, ages within approximately two years, discordant health. For sicker \(i\), healthier \(j\), use \(\operatorname{softplus}[-(h_i-h_j)]\).

   **Success:** health prediction on an excluded clinical target, reproducible patient rankings across seeds, and no advantage explained solely by sex or procedure.

   **Main deception:** the factors acquire convenient names without becoming identifiable biological quantities. Supervision and assumptions matter; unsupervised disentanglement alone cannot resolve this ([Locatello et al., 2019](https://proceedings.mlr.press/v97/locatello19a.html)).

5. **Distributional age and age-conditioned atypicality**

   Replace the point age head with noncrossing 0.1/0.5/0.9 quantiles trained using pinball loss. Test whether interval width or standardized age discrepancy adds health prediction beyond the existing gap.

   For literal “unusual pulse for this age,” fit an age/sex-conditioned Gaussian to eight training-derived embedding principal components, using shrinkage covariance and Gaussian negative log likelihood. Evaluate Mahalanobis atypicality. An age posterior \(P(A\mid z)\) is a different quantity from \(P(z\mid A)\).

   **Success:** calibrated age-conditional coverage and incremental health prediction beyond point estimates and quality measures.

   **Main deception:** unusual signals reflect motion, device characteristics or benign anatomy. Atypicality has no inherent “older” direction.

Several safeguards are essential to the biological-age interpretation:

- **Residual age dependence:** inspect spline trends and conditional variance; zero Pearson correlation does not establish age independence.
- **Simpson’s paradox and selection:** show age-, sex- and procedure-stratified results. Conditioning on surgical participation can itself induce associations; internal adjustment cannot establish population transportability.
- **ASA circularity:** predicting ASA is legitimate supervised prediction, but `healthy` supplies overlapping evidence. Validate against excluded labs, functional measurements and eventually incident outcomes.
- **Treatment confounding:** compare available pre-induction and intraoperative windows; adjust or stratify by documented treatment. Those adjustments do not make observational drug responses causal.
- **Mechanical age contamination:** eGFR embeds age and sex. Prefer creatinine with explicit adjustment when studying separation from chronological age.
- **Sample size and repeated testing:** millions of windows remain thousands of people. Bootstrap people; seeds do not increase sample size. Three test deaths support neither mortality modeling nor meaningful mortality validation. The repeatedly inspected test set now provides exploratory evidence.
- **Reliability versus aging:** measure agreement between disjoint window sets and repeat visits. Acute physiological variation is not evidence of a changed aging rate.

For a watch, the transferable elements are the streaming architecture, self-supervised objectives, quality control and repeated-measure design. Finger-derived weights, risk calibration, anesthesia responses, BP accuracy and PAT interpretation all require new validation. GalaxyPPG’s young participants cannot validate an aging score.

Also, the encoder is causal but current preprocessing uses **zero-phase filtering and whole-window scaling**. A causal deployment pipeline needs explicit validation.

A self-collected cohort should cross age with health status, collect paired finger/watch recordings across repeated visits, and record motion, medications, cuff BP, labs and functional measures. A standardized standing or walking-recovery protocol could test dynamic reserve. Hold out people and later sessions; reserve biological-age claims for prospective validation.

Tomorrow’s minimal experiment is **candidate 2 with candidate 1’s ASA target**:

- On the cluster holding run 3, use `Pool`, `_eval_index`, `load_encoder`, `encode` and `embedding` to extract frozen embeddings from 20 fixed windows per person—approximately 118,000 windows. Keep the encoder in evaluation mode.
- Average embeddings per person. Fit three penalized logistic models: age spline + sex; that baseline + raw embedding; and that baseline + residualized embedding. Existing `fit_logistic` and SciPy suffice.
- Select penalties within training, calibrate on validation, then evaluate test once. Assess score reliability using two disjoint ten-window subsets.
- Predeclare success as improved log loss, a paired ΔAUC interval above zero, and consistent within-age performance. Report the score before attempting years.

Budget **15–30 minutes on one A100**, including I/O, small-model fitting and bootstrap evaluation, assuming prepared data and checkpoint are available. This is an estimate. The decisive result is whether the ASA gain survives stronger demographic adjustment and remains reproducible across windows.